首页> 外国专利> METHOD FOR PREDICTING THE EFFECTIVENESS OF THERAPY USING ORAL HYPOGLYCEMIC AGENT METFORMIN IN PATIENTS WITH TYPE 2 DIABETES

METHOD FOR PREDICTING THE EFFECTIVENESS OF THERAPY USING ORAL HYPOGLYCEMIC AGENT METFORMIN IN PATIENTS WITH TYPE 2 DIABETES

机译:口服降糖药二甲双胍预测2型糖尿病患者治疗效果的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, and concerns a method for predicting the efficacy of monotherapy with oral antidiabetic drug metformin in patients with type 2 diabetes. Method consists in the fact that in patients with type 2 diabetes DNA is extracted from peripheral venous blood, followed by polymerase chain reaction (PCR) and conducting analysis to detect polymorphism AC rs 622342 of OST1 gene. When identifying genotype AA in the area rs 622342 of OST1 gene predict the effectiveness of monotherapy with metformin as antidiabetic drug in patients with type 2 diabetes, and when identifying genotype AC and CC in the area rs 622342 of OST1 gene predict the ineffectiveness of monotherapy with metformin as antidiabetic drug in this group of patients.;EFFECT: use of the method allows to increase the accuracy and specificity of predicting the effectiveness of monotherapy of oral antihyperglycemic drug metformin in patients with type 2 diabetes.;1 cl, 2 tbl, 3 ex
机译:药物领域:本发明涉及药物,并且涉及预测口服抗糖尿病药二甲双胍对2型糖尿病患者的单一疗法的疗效的方法。该方法包括以下事实:在2型糖尿病患者中,从外周静脉血中提取DNA,然后进行聚合酶链反应(PCR)并进行分析以检测OST1基因的多态性A> C rs 622342。当在OST1基因的rs 622342区域中鉴定基因型AA时,预测用二甲双胍作为2型糖尿病患者的抗糖尿病药的有效性;当在OST1基因的rs 622342区域中鉴定AC和CC的基因型时,则预测单药治疗无效。二甲双胍作为该组患者的抗糖尿病药。效果:使用该方法可以提高预测口服抗高血糖药二甲双胍对2型糖尿病患者单一疗法有效性的准确性和特异性。1cl,2 tbl,3前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号